Epiq Capital Group, LLC Bluebird Bio, Inc. Transaction History

Epiq Capital Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$8.96 - $16.31 $253,075 - $460,675	-28,245 Closed	0 $0
Q4 2020 Feb 01, 2021	SELL	$27.5 - $37.92 $709,115 - $977,805	-25,786 Reduced 47.72%	28,245 $1.22 Million
Q2 2020 Jul 27, 2020	BUY	$27.12 - $45.97 $169,554 - $287,404	6,252 Added 13.09%	54,031 $3.3 Million
Q1 2020 Jun 18, 2020	BUY	$26.16 - $63.5 $548,025 - $1.33 Million	20,949 Added 78.08%	47,779 $2.2 Million
Q4 2019 Jun 18, 2020	BUY	$46.96 - $61.67 $1.26 Million - $1.65 Million	26,830 New	26,830 $2.35 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Epiq Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Epiq Capital Group, LLC with notifications on news.